Next Article in Journal
Key Strategies to Optimize Outcomes in Mild-to-Moderate Ulcerative Colitis
Previous Article in Journal
Overview of the Side-Effects of FDA- and/or EMA-Approved Targeted Therapies for the Treatment of Hematological Malignancies
 
 
Due to scheduled maintenance work on our database systems, there may be short service disruptions on this website between 10:00 and 11:00 CEST on June 14th.
Article

Article Versions Notes

J. Clin. Med. 2020, 9(9), 2904; https://doi.org/10.3390/jcm9092904
Action Date Notes Link
article xml file uploaded 8 September 2020 14:45 CEST Original file -
article xml uploaded. 8 September 2020 14:45 CEST Update -
article pdf uploaded. 8 September 2020 14:45 CEST Version of Record -
article xml file uploaded 8 September 2020 14:46 CEST Update -
article xml uploaded. 8 September 2020 14:46 CEST Update -
article pdf uploaded. 8 September 2020 14:46 CEST Updated version of record -
article xml file uploaded 8 September 2020 14:46 CEST Update -
article xml uploaded. 8 September 2020 14:46 CEST Update https://www.mdpi.com/2077-0383/9/9/2904/xml
article pdf uploaded. 8 September 2020 14:46 CEST Updated version of record https://www.mdpi.com/2077-0383/9/9/2904/pdf
article html file updated 8 September 2020 14:47 CEST Original file -
article html file updated 8 September 2020 14:47 CEST Update -
article html file updated 8 September 2020 14:47 CEST Update -
article html file updated 22 July 2022 06:26 CEST Update https://www.mdpi.com/2077-0383/9/9/2904/html
Back to TopTop